Evasion and Subversion of Interferon-Mediated Antiviral Immunity by Kaposi's Sarcoma-Associated Herpesvirus: an Overview

scientific article published on July 20, 2011

Evasion and Subversion of Interferon-Mediated Antiviral Immunity by Kaposi's Sarcoma-Associated Herpesvirus: an Overview is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.00687-11
P953full work available at URLhttps://doi.org/10.1128/jvi.00687-11
https://europepmc.org/articles/PMC3194983
https://europepmc.org/articles/PMC3194983?pdf=render
https://journals.asm.org/doi/pdf/10.1128/JVI.00687-11
https://jvi.asm.org/content/jvi/85/21/10934.full.pdf
P932PMC publication ID3194983
P698PubMed publication ID21775463
P5875ResearchGate publication ID51508024

P2093author name stringYan Yuan
Narayanan Sathish
P2860cites workAids-related malignanciesQ22251046
A Toll-like receptor recognizes bacterial DNAQ24290668
Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinaseQ24290751
A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.Q24293762
Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3...Q24297037
Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated DegradationQ24523761
Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.Q24531182
Early events in Kaposi's sarcoma-associated herpesvirus infection of target cellsQ37634746
Virion proteins of Kaposi's sarcoma-associated herpesvirusQ37744006
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arraysQ38305362
Multiple regulatory domains control IRF-7 activity in response to virus infectionQ38310560
Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription.Q38341017
Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infectionQ38610318
Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1.Q39305101
Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.Q39551686
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteinsQ39585165
Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factorsQ39593162
Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfateQ39606465
Modulation of Interferon Regulatory Factor 5 Activities by the Kaposi Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3 Contributes to Immune Evasion and Lytic InductionQ39623528
Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysisQ39683622
A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulationQ39910021
Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cellsQ39996542
Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.Q40128654
Kaposi's sarcoma: a review of the classical and epidemic formsQ40203223
Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein.Q40311533
Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.Q40364647
New viruses shake old paradigmsQ40364721
Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B.Q40468638
Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infectionQ40598301
Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.Q40608568
Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moietiesQ40802330
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).Q40961025
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequencesQ40971183
Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptorsQ40990994
Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in cultureQ41225141
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus.Q41365661
Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon responseQ41810499
A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transductionQ41898857
Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?Q41984354
Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.Q42227558
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathwayQ42834462
ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infectionQ42931199
Interferon-β is required for interferon-α production in mouse fibroblastsQ43412872
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonQ44860628
The murine double-stranded RNA-dependent protein kinase PKR and the murine 2',5'-oligoadenylate synthetase-dependent RNase L are required for IFN-beta-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion cultureQ45721999
In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumorsQ45854965
The Transcriptional Activity of cAMP Response Element-binding Protein-binding Protein Is Modulated by the Latency Associated Nuclear Antigen of Kaposi's Sarcoma-associated HerpesvirusQ57662902
Kaposi's sarcoma: a reversible hyperplasiaQ69890531
HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivatorsQ73787690
Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible GenesQ77137033
Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7Q77758397
The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradationQ81304838
Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300Q24533140
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7Q24533409
Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domainQ24551074
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)Q24650427
LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIFQ24672442
Interferon-inducible antiviral effectorsQ27486790
Identification of Caspase-mediated Decay of Interferon Regulatory Factor-3, Exploited by a Kaposi Sarcoma-associated Herpesvirus Immunoregulatory ProteinQ27489720
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s SarcomaQ27636336
Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivationQ27642340
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteinsQ27860890
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6Q28115232
PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 geneQ28139719
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathwayQ28190704
Triggering the interferon antiviral response through an IKK-related pathwayQ28191761
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcomaQ28242984
Mechanisms of type-I- and type-II-interferon-mediated signallingQ28247893
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptorsQ28260114
Regulation of the type I IFN induction: a current viewQ28276339
Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6Q28292248
Toll-like receptors in innate immunityQ28297257
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infectionQ28299060
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasQ28299069
IRF-7 is the master regulator of type-I interferon-dependent immune responsesQ28511410
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathwayQ28592087
Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domainsQ28608956
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signalingQ28646137
Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Q29394711
MyD88 Is an Adaptor Protein in the hToll/IL-1 Receptor Family Signaling PathwaysQ29616209
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasuresQ29618978
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's diseaseQ29619158
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene inductionQ29620054
The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virionsQ30453077
Multiplex detection and quantitation of latent and lytic transcripts of human herpesvirus-8 using RNase Protection AssayQ31121261
Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirusQ31156919
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosisQ35175590
Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesisQ35185925
Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptorsQ35656534
Inferences, questions and possibilities in Toll-like receptor signallingQ35829752
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.Q35874857
A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.Q35885525
Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expressionQ36099240
Type I interferons keep activated T cells aliveQ36367751
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cellsQ36371359
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicityQ36446460
Conserved herpesvirus protein kinasesQ36491044
Kaposi's sarcoma-associated herpesvirus immune modulation: an overviewQ36499704
Triggering the innate antiviral response through IRF-3 activationQ36774934
Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declinQ37010247
Interferon regulatory factor family of transcription factors and regulation of oncogenesisQ37055295
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5Q37136785
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesisQ37307209
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcomaQ37535731
Herpesvirus assembly: an updateQ37570980
Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signalingQ37585525
Viral interferon regulatory factorsQ37588733
A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirusQ33559699
Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.Q33582093
Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.Q33649357
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expressionQ33653424
Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoterQ33748042
KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicineQ33761091
Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory FactorQ33784902
Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirusQ33815257
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53Q33834993
Herpes simplex virus triggers and then disarms a host antiviral responseQ33835458
Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus).Q33841257
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigenQ33859518
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factorQ33966269
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.Q33967257
Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1)Q34069105
miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator.Q34112056
Structure and function of IRF-7.Q34114255
Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells.Q34192731
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latencyQ34194120
A weak signal for strong responses: interferon-alpha/beta revisitedQ34238056
Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCRQ34340317
Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activationQ34378427
Clinical presentation and natural history of AIDS--related Kaposi's sarcomaQ34403706
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.Q34408877
Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45Q34452746
Apoptosis and Cell Growth Inhibition as Antitumor Effector Functions of InterferonsQ34485664
Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 functionQ34532718
Enhancement and diversification of IFN induction by IRF-7-mediated positive feedbackQ34532725
Kaposi Sarcoma-associated Herpesvirus Degrades Cellular Toll-Interleukin-1 Receptor Domain-containing Adaptor-inducing β-Interferon (TRIF)Q34624150
Regulation of adaptive immunity by the innate immune systemQ34659642
Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitryQ34979001
Structure and function of latency-associated nuclear antigenQ35124429
Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.Q35150010
NF-kappaB inhibits gammaherpesvirus lytic replicationQ35155154
P433issue21
P407language of work or nameEnglishQ1860
P921main subjectevasion of host immune responseQ1660157
P304page(s)10934-10944
P577publication date2011-07-20
P13046publication type of scholarly workreview articleQ7318358
P1433published inJournal of VirologyQ1251128
P1476titleEvasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview
Evasion and Subversion of Interferon-Mediated Antiviral Immunity by Kaposi's Sarcoma-Associated Herpesvirus: an Overview
P478volume85

Reverse relations

cites work (P2860)
Q37992879Activation and regulation of interferon-β in immune responses.
Q64969424Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.
Q38838059Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
Q64093190Extracellular Vesicles From KSHV-Infected Cells Stimulate Antiviral Immune Response Through Mitochondrial DNA
Q30603461Fluorescent tagging and cellular distribution of the Kaposi's sarcoma-associated herpesvirus ORF45 tegument protein
Q30406863Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses
Q38408315Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways
Q36169636Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces Cytoplasmic Interferon-β Responses.
Q90100096Homology-directed repair in mouse cells increased by CasRx-mediated knockdown or co-expressing Kaposi's sarcoma-associated herpesvirus ORF52
Q33677823Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.
Q35208258Influence of ND10 components on epigenetic determinants of early KSHV latency establishment
Q36052710Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein
Q34615002Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system
Q37308737Intracellular interferons in fish: a unique means to combat viral infection
Q89770486Kaposi Sarcoma-associated herpesvirus infection and endemic Burkitt's lymphoma
Q40417350Kaposi's Sarcoma-Associated Herpesvirus Infection of Neurons in HIV-Positive Patients
Q99552055Kaposi's sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya
Q41831354Mouse gammaherpesvirus-68 infection acts as a rheostat to set the level of type I interferon signaling in primary macrophages
Q36359794NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
Q47551073RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism
Q39284842Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update
Q27010116Recognition of human oncogenic viruses by host pattern-recognition receptors
Q64375144Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene
Q90483351Regulation of cGAS-Mediated Immune Responses and Immunotherapy
Q37995595Tegument Proteins of Kaposi’s Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses
Q47927359Tetrabromobisphenol A activates the hepatic interferon pathway in rats
Q40237439The Heme Metabolite Carbon Monoxide Facilitates KSHV Infection by Inhibiting TLR4 Signaling in Endothelial Cells
Q42266941The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression.
Q96828977USP7 manipulation by viral proteins
Q30384388Viruses and human cancers: a long road of discovery of molecular paradigms.

Search more.